Concord Biotech Board Meeting on July 31, 2026 for Q1 Results

Concord Biotech Ltd has scheduled a Board of Directors meeting for July 31, 2026. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, along with the limited review report from the statutory auditors. Additionally, the company confirmed that the trading window for dealing in its securities will remain closed until 48 hours after the declaration of these financial results, in compliance with SEBI regulations and the company's code of conduct regarding insider trading.